Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec;15(6):803-810.
doi: 10.18502/ijm.v15i6.14161.

Persistence of SARS-CoV-2-antibodies against N, S and RBD after natural infection

Mitra Jafari  1 , Samira Asli  2 , Fateme Moghbeli  3 , Mohammad Gholami Fesharaki  4 , Nazila Hajiahmadi  1 , Faezeh Mojtahedzadeh  1 , Saeid Amel Jamehdar  2   5 , Taravat Bamdad  1
Affiliations

Persistence of SARS-CoV-2-antibodies against N, S and RBD after natural infection

Mitra Jafari et al. Iran J Microbiol. 2023 Dec.

Abstract

Background and objectives: Coronavirus disease 2019 (COVID-19) pandemic has affected most countries in the world. Monitoring the humoral immune responses during the natural course of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection and the duration of them provide useful information for the development of vaccination strategies against this virus and its emerging variants. The importance of the antibody response especially neutralizing antibodies in long-term immunity to SARS-CoV-2 is significant.

Materials and methods: The present study is a cross-sectional study of sero-epidemiological type that has been proposed to compare the persistence of Immunoglobulin G (IgG) against N (nucleocapsid), S (spike) and RBD (receptor-binding domain) proteins in the community after the time of primary disease. A total of 652 serum samples were collected from hospital staff working in COVID wards, as well as a number of community members with different occupations, among those with positive antibody titers, 86 participated in the resampling test before vaccination.

Results: There was no association between antibody titer and disease severity (p>0.05). A significant decrease in Ab levels was observed in the paired second samples. The highest rate of decrease was related to anti-N, then anti-RBD and anti-S IgG levels, respectively. There is a significant relationship between the initial antibody titer and its reduction over time (p-value <0.05).

Conclusion: Our data revealed that humoral immunity following natural infection of SARS-CoV-2 is detectable for at least 4 months, regardless of disease severity. The most decrease in antibody titer over time was related to anti-N IgG levels.

Keywords: Antibody persistence; COVID-19; Humoral immunity; Long-term immunity; SARS-CoV-2.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
The mean of N, S and RBD Ab titers based on covid-19 symptoms. There is no Association among titers and disease symptoms (p>0.05). *Antibody level based on OD of sample to cut-off(S/Co)
Fig. 2.
Fig. 2.
Dynamics of anti-N IgG antibody levels in paired serum samples *Antibody level based on OD of sample to cut-off(S/Co)
Fig. 3.
Fig. 3.
Dynamics of anti-RBD IgG antibody levels in paired serum samples
Fig. 4.
Fig. 4.
Dynamics of anti-S IgG antibody levels in paired serum samples *Antibody level based on OD of sample to cut-off (S/Co)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Adams ER, Ainsworth M, Anand R, Andersson MI, Auckland K, Baillie JK, et al. Antibody testing for COVID-19: a report from the National COVID Scientific Advisory Panel. Wellcome Open Res 2020; 5: 139. - PMC - PubMed
    1. Long Q-X, Liu B-Z, Deng H-J, Wu G-C, Deng K, Chen Y-K, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med 2020; 26: 845–848. - PubMed
    1. Robbiani DF, Gaebler C, Muecksch F, Lorenzi JC, Wang Z, Cho A, et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature 2020; 584: 437–442. - PMC - PubMed
    1. Hanson KE, Caliendo AM, Arias CA, Englund JA, Lee MJ, Loeb M, et al. Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19. Clin Infect Dis 2020: ciaa760. - PMC - PubMed
    1. Favresse J, Eucher C, Elsen M, Gillot C, Van Eeckhoudt S, Dogné J-M, et al. Persistence of anti-SARS-CoV-2 antibodies depends on the analytical kit: a report for up to 10 months after infection. Microorganisms 2021; 9: 556. - PMC - PubMed

LinkOut - more resources